bioRxiv Science⌕ Search

Biology subjects

Zill, N. A.

Publications and source records attributed to Zill, N. A..

3 recordsLinked to original sources

Bioactive Natural Product Discovery via Deuterium Adduct Bioactivity Screening

The discovery of bioactive natural products lies at the forefront of human medicine. The continued discovery of these molecules is imperative in the fight against infection and disease. While natural products have historically dominated the drug market, discovery in recent years has slowed significantly, partly due to limitations in current discovery methodologies. This work demonstrates a new workflow, Deuterium Adduct Bioactivity Screening (DABS), which pairs untargeted isotope labeling with whole cell binding assays for bioactive natural product discovery. DABS was validated and led to the discovery of a new isoprenyl guanidine alkaloid, zillamycin, which showed anti-cancer and anti-microbial activities. DABS thus represents a new workflow to accelerate discovery of natural products with a wide range of bioactive potential.

microbiology↗

Total Biosynthesis of Triacsin Featuring an N-hydroxytriazene Pharmacophore

Triacsins are an intriguing class of specialized metabolites possessing a conserved N-hydroxytriazene moiety not found in any other known natural products. Triacsins are notable as potent acyl-CoA synthetase inhibitors in lipid metabolism, yet their biosynthesis has remained elusive. Through extensive mutagenesis and biochemical studies, we here report all enzymes required to construct and install the N-hydroxytriazene pharmacophore of triacsins. Two distinct ATP-dependent enzymes were revealed to catalyze the two consecutive N-N bond formation reactions, including a glycine-utilizing hydrazine-forming enzyme, Tri28, and a nitrous acid-utilizing N-nitrosating enzyme, Tri17. This study paves the way for future mechanistic interrogation and biocatalytic application of enzymes for N-N bond formation.

biochemistry↗

Adaptation of Mycobacterium tuberculosis to biofilm growth is genetically linked to drug tolerance

Mycobacterium tuberculosis (Mtb) spontaneously grows at the air-medium interface forming pellicle biofilms, which harbor more drug tolerant persisters than planktonic cultures. The underlying basis for increased persisters in Mtb biofilms is unknown. Using a Tn-seq approach, we show here that multiple genes that are necessary for fitness of Mtb cells within biofilms, but not in planktonic cultures, are also important for their tolerance to a diverse set of stressors and antibiotics. Thus, development of Mtb biofilms appears to be associated with population enrichment, in which endogenous stresses presumably generated by challenging growth conditions within biofilm architecture select for cells that maintain tolerance to exogenous stresses including antibiotic exposure. We further observed that the intrinsic drug tolerance of constituent cells of biofilms determines the frequency of persisters: morphologically indistinguishable monoculture biofilms of a {Delta}pstC2A1 mutant hypersensitive to rifampicin harbor [~]20-fold fewer persisters than wild-type. These findings together allow us to propose that the selection of elite cells during biofilm development significantly contributes to the persister frequency. Furthermore, probing the possibility that the population enrichment is an outcome of unique environment within biofilms, we demonstrate biofilm-specific induction in the synthesis of isonitrile lipopeptides (INLP). Mutation analysis indicates that INLP is necessary for the architecture development of Mtb biofilms. In summary, the study offers an insight into persistence of Mtb biofilms under antibiotic exposure, while identifying INLP as a biomarker for further investigation of this phenomenon.\n\nSIGNIFICANCEThe tuberculosis (TB) pathogen Mycobacterium tuberculosis (Mtb) is one of the deadliest bacterial pathogens known to mankind, and TB treatment is inefficient. A lengthy chemotherapy for TB is attributed to a small subpopulation of Mtb bacilli exhibiting phenotypic tolerance to antibiotics. Drugs targeting these persisters are expected to shorten TB chemotherapy, but their development is dependent on in vitro growth models that reproducibly generate high frequency of persisters. Biofilms of Mtb are a suitable model for understanding the origin of persisters. Here, we provide an explanation for the elevated persister frequency in Mtb biofilms. We also identify isonitrile lipopetides as a biomarker of Mtb biofilms. These findings will facilitate further advancements of our efforts to identify and target Mtb persisters.

microbiology↗